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Background: Obesity is proposed to represent an important predisposing condition to
serious respiratory disturbances including asthma. The effects of consistent weight loss on
asthma control are not well known. We investigated the effect of weight reduction
induced by bariatric surgery on asthma control in severely obese asthmatic patients.
Patients and methods: A consecutive series of 12 asthmatic obese females who had
laparoscopic adjustable gastric banding (OB group) and 10 non-operated asthmatic obese
females as control group (CG). Body mass index (BMI), Asthma Control Test (ACT),
pulmonary function test (PFT), exhaled nitric oxide (NO) were evaluated at baseline and
after 1 year.
Results: Mean BMI (kg/m2) of OB group decreased from 45.274.7 before surgery to
34.874.2 post-operatively. After surgery the overall ACT score in OB group significantly
improved from 18.7 to 22.2 (po0.001), while it remained unchanged in CG (from 18.8 to
18.6, p ¼ 0.73). In particular, in OB group the parameters of shortness of breath and rescue
medication use were significantly improved respectively from 3.2 and 3.9 before surgery to
4.2 and 4.6 after surgery (always po0.05). Accordingly, none of the CG who did not
experience any weight loss was able to obtain a full asthma control. In the OB group after
the surgery PFT significantly improved as compared to CG. No significant difference in
exhaled NO was found both in OB group after surgery as compared to before surgery.Elsevier Ltd. All rights reserved.
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Asthma and obesity 103Conclusion: Consistent weight loss in severely obese patients with asthma is associated to
improvement in respiratory symptoms and lung function. However, the mechanisms
underlying the effect of large body mass changes on asthma would require further studies.
& 2007 Elsevier Ltd. All rights reserved.Introduction
Obesity, the most common nutritional disorder in humans, is a
major cause of mortality and morbidity for associated
disorders1,2 and it might represent an important predisposing
condition to serious respiratory disturbances including asthma.
Several studies have reported the association between obesity
and asthma prevalence.3–7 In fact, obesity may affect lung
function and contribute to an increase in asthma severity.8,9
On the other hand, weight loss may improve lung function and
oxygenation in obesity,10,11 and improvement in asthma
severity has been reported in adult obese asthmatics after
weight loss.12,13 However, only few studies,13–17 mostly retro-
spective or focused on obesity comorbidities, have evaluated
the effects of weight loss attained by bariatric surgery on
asthma control, currently defined according to a set of
treatment goals, thus giving an assessment of asthma.
Recently, attention has focused on the assessment of
asthma control with the use of validated questionnaires such
as the Asthma Control Test (ACT),18 evaluating activity level,
sleep disturbance, the need for rescue albuterol and the global
assessment of asthma control. The ACT has been validated as
an instrument that can effectively track asthma control status
over time.18,19 Similarly, measurement of exhaled nitric oxide
(NO) has been increasingly used as a marker of disease
activity20–22 and a tool to control to the therapy in asthma.23
Therefore, we investigated whether weight loss induced
by bariatric surgery affects lung function, asthma control
and exhaled NO in obese patients with asthma.
Materials and methods
Patients
Twenty-two consecutive severe obese females with previous
diagnosis of intermittent or mild to moderate asthma and
attending for laparoscopic adjustable gastric banding (LAGB)
evaluation to our bariatric surgery clinic were enrolled. All
patients were non-smoker or had stopped smoking for 2 years or
more. The diagnosis of asthma was conformed to the criteria of
the GINA.24 Atopy was determined on the basis of positive wheal
responses (43mm) to 12 common airborne allergen extracts,
using a standardized skin prick test kit (Allergopharma, Hamburg,
Germany). Exclusion criteria included the following: cardio-
respiratory disturbances, obstructive sleep apnea, history of
upper respiratory tract infection. Characteristics of the patients
and anti-asthmatic medications are presented in Table 1.
Twelve patients underwent the laparoscopic adjustable
gastric banding by pars flaccida technique25 (OB group)
while 10 who refused or were excluded from the surgery
represented the control group (CG).
No post-operative complications were recorded in OB
group. The study protocol was approved by the local ethics
committee.Measurements
The weight (kg) and height (m) were determined between 9
and 11a.m. with the subject barefoot and dressed in very light
clothing. From these, the body mass index (BMI) was calculated
as the ratio of weight to height squared for each subject.ACT survey
To assess the asthma control the ACT survey was used. The
ACT survey is a patient-completed questionnaire with five
items assessing asthma symptoms (daytime and nocturnal),
use of rescue medications, and the effect of asthma on daily
functioning. Each item includes five response options
corresponding to a five-point Likert-type rating scale. In
scoring the ACT survey, responses for each of the five items
are summed to yield a score ranging from 5 (poor control of
asthma) to 25 (complete control of asthma).Measurement of exhaled NO
NO was detected by a chemiluminescent analyzer (280 NOA
Sievers Instruments, Boulder, Sensor Medics, Milan, Italy),
characterized by a lower detection limit of 1 (parts per
billion) ppb and a NO sampling rate of 200mL/min. Daily
two-point calibration was performed with zero gas (Zero Air
Filter, Sievers) and a certified NO gas mixture at 101 ppb
(SIAD Osio, Italy). All NO measurements were performed
when the patients were fasting.
The method recommended for online measurement of the
exhaled NO concentration in adults was employed.22 After a
full inspiration from room air, subjects exhaled for 10 s
through restrictors against positive pressures of 10 cmH2O to
generate flow rates of 50mL/s. This technique allows closing
the velum, thus excluding nasal NO during expiration.Pulmonary function test measurements
Lung volumes and flow rates were determined using auto-
mated equipment (V Max 22 System SensorMedics, Milan,
Italy). Forced inspiratory and expiratory maneuvers were
performed three times and the best value obtained from the
maximum inspiratory and expiratory flow-volume curves
were used for comparison. Recommendation for standardized
procedures for various lung function tests was followed.23Experimental procedure
Each person was tested baseline in the run-in period and
after 1 year. The PFTs, exhaled NO measurements and ACT
questionnaire were performed the same day within 1 month
of operation. The PFT and NO measurements and the ACT
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Table 1 Baseline characteristics of patients.
Sex Age
(years)
Smoke Weight (kg) BMI
(kg/m2)
Atopy Asthma
DUR
(years)
GINA
classifica-
tion
Medications
(mg)
OB
1 F 53 N 150 53 P, G, D 18 Mild per Bud 400 bid
2 F 43 N 125 43 P, D 12 Mild per Bud 200 bid
3 F 54 N 114 47 P 10 Mild per Bud 200 bid
4 F 34 E 128 47 P, G 12 Intermit-
tent
Salb prn
5 F 21 N 120 47 P, G 6 Mild per Becl 500 bid
6 F 20 N 110 40 P 10 Moderate
per
Bud 400 bid,
salm
7 F 53 E 103 38 P, D 12 Mild per Bud 200 bid
8 F 35 N 92 40 P, G, 22 Intermit-
tent
Salb prn
9 F 37 N 123 48 P, G, D 30 Moderate
per
Bud 400 bid,
salm
10 F 55 N 100 44 G 35 Intermit-
tent
Salb prn
11 F 48 N 109 43 P, G 22 Mild per Bud 400 bid
12 F 56 E 110 52 P, G 18 Intermit-
tent
Salb prn
Mean7SD 42.4713 115.3715.3 45.274.7 17.278.7
CG
1 F 43 N 131 45 D 11 Moderate
per
Bud 400 bid,
Salm
2 F 31 N 128 46 P, D 15 Intermit-
tent
Salb prn
3 F 44 N 100 41 D 30 Intermit-
tent
Salb prn
4 F 37 E 128 47 P, G 18 Mild per Becl 500 bid
5 F 25 N 105 43 P 10 Mild per Becl 500 bid
6 F 24 N 98 40 P 6 Mild per Bud 400 bid
7 F 33 E 122 45 P, D 8 Mild per Bud 200 bid
8 F 38 N 111 47 P, G, 25 Intermit-
tent
Salb prn
9 F 37 N 113 45 P, D 21 Mild per Bud 200 bid
10 F 45 E 98 42 D 30 Intermit-
tent
Salb prn
Mean7SD 35.777.0 113713.0 4472.5 17.478.8
OB: obese asthmatic who underwent bariatric surgery; CG: obese asthmatic who refused surgery; F: female; N: non-smoker; E: ex
smoker; P: parietaria; G: grass pollen; D: dermatophagoides; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; per:
persistent; bud: budesonide; becl: beclomethasone; salm: salmeterol; salb prn: salbutamol prn as required; bid: bis in die.
M. Maniscalco et al.104questionnaire were repeated 1 year post-operatively in OB
group and after 1 year in CG.
All measurements were made at lunchtime. All subjects
were fasted for 4 h before the tests. The subjects weight and
height were measured immediately before the start of the
experiment.
Patients had been advised not to change their anti-
asthmatic treatment other than short-acting b2-agonists
during the study if the stability of asthma was clinically
acceptable. Patients with allergy to pollen were studied out
of season. The dose and timing of long-acting b2-agonists
were identical at study visits before and after weight loss.Patients did not consume any short-acting bronchodilators
for 4 h before pulmonary function tests.Statistics
Data are presented as means7standard deviation. Two-
sample paired t-test was used to evaluate differences
between patients at baseline and after 1 year. Two-sample
unpaired t-test was used to compare OB group and CG.
Pearson or Spearman correlation coefficients were used to
assess the association between categorical variables,
ARTICLE IN PRESS
Table 2 Absolute values (mean7S.D.) and changes (D) in weight, BMI, asthma control test (ACT), exhaled nitric oxide (eNO)
and spirometric data for each study group at baseline and after 1 year follow-up.
OB group Control group p-Value
Baseline Follow-up Baseline Follow-up
Weight (kg) 115.3715.3 89.078.5 113.0713.0 118.077.1
DWeight (%) 22 +4.4 o0.001
BMI (kg/m2) 45.274.7 34.874.2 44.072.5 45.375.1
DBMI (%) 23 +2.9 o0.001
ACT score 18.772.6 22.272.2 18.871.6 18.671.5
DACT score (%) +19 1.1 o0.001
eNO (ppb) 35.776.3 36.476.0 32.976.4 35.076.1
DeNO (%) +2.0 +6.4 0.2
FEV1 (L) 83.0714.4 87.2714.9 82.377.5 84.5711.3
DFEV1 (%) +5.1 +2.6 0.02
FVC (L) 87.8713.5 95.2710.7 87.1710.3 86.1711.5
DFVC (%) +8.4 1.2 0.001
∗
Asthma and obesity 105anthropometrics measures, spirometric data and exhaled
NO. A p-value less than 0.05 was considered significant.Baseline 1 year
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25 NSResults
Weight reduction
No difference in mean weight was found between OB group
before surgery and CG at baseline (p ¼ 0.48).
Mean weight in the OB group before surgery was
115.3715.3 kg and it significantly decreased 1 year after
surgery (89.078.5 kg, po0.0001). At this point, patients
had lost at least 20% of their BMI (from 45.274.7 to
34.874.2, po0.0001). In the CG the baseline mean weight
was 113.0713.0 kg and no significant difference was found
after 1 year (118.0717.1 kg, p ¼ 0.6) (Table 2).Baseline 1 year
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Figure 1 Asthma Control Test (ACT) score in (a) 12 obese
subjects affected by asthma before and 1 year after weight loss
induced by bariatric surgery, *po0.005; (b) 10 not-operated
obese subjects affected by asthma at baseline and after 1 year,
NS: not significant.ACT survey
Baseline ACT score was not significantly different between
OB group before surgery and CG (p ¼ 0.9).
Figure 1 displays the overall perception of health status of
OB group before and after the surgery. After surgery the
overall ACT score significantly improved from 18.7 to 22.2
(po0.001). In eight obese patients before surgery the ACT
score was p19, whereas only one patient had a score p19
after surgery. Furthermore, 10 among 12 obese patients
after surgery referred a marked improvement of asthma
control as compared to the pre-surgery condition referring
perceived excellent or good overall health. On the other
hand, one reported a worsening and one no changes as
compared to before surgery.
All five ACT parameters were improved consistently. In
particular, the parameters of shortness of breath and rescue
medication use were significantly improved respectively
from 3.2 and 3.9 before surgery to 4.2 and 4.6 after surgery
(always po0.01). No correlation was found between either
the overall ACT score or the single ACT parameters and BMI
(always p40.05).In the CG no significant changes between baseline value
and after 1 year in the overall ACT score (from 18.871.6 at
baseline to 18.671.5 after 1 year, p ¼ 0.73) (Figure 1) or in
each five ACT parameters were found. In particular, only two
reported an improvement of asthma control after 1 year,
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asthma control.
Exhaled NO
Baseline exhaled NO was not significantly different bet-
ween OB group before surgery and control group (p ¼ 0.31)
(Table 2).
Exhaled NO in OB group before surgery was 35.776.3 ppb
and it was not affected by weight loss induced by bariatric
surgery (36.476.0 ppb, p ¼ 0.42).
Similarly, in the CG exhaled NO was not different from
baseline after 1 year (from 32.976.4 to 35.076.1 ppb,
p ¼ 0.46).
No correlation was found between BMI and the absolute
value of exhaled NO in OB group before surgery (r ¼ 0.38,
p ¼ 0.23) or the reduction in BMI and the difference in
exhaled NO after surgery (r ¼ 0.4, p ¼ 0.18).
No correlation between exhaled NO and each five ACT
parameter was found in either group at baseline or
follow-up.
Pulmonary function tests
No differences in FEV1 and FVC were found between OB
group before surgery and CG at baseline (always p40.7).
No correlation between BMI and FEV1 and FVC was found
in OB group (always p40.3)
In OB group the FEV1 (% of predicted) increased
significantly 1 year after the surgery from 83.0714.4 to
87.2714.9 L, p ¼ 0.009. Similarly, the FVC (% of predicted)
improved 1 year after the surgery from 87.8713.5 to
95.2710.7 L, p ¼ 0.001.
No significant difference in FVC and FEV1 was found in CG
after 1 year (FVC 87.1710.3 and 86.1711.5 L, FEV1
82.377.5 and 84.5711.3 L) (Table 2).
Discussion
This study shows that the weight reduction in severe obese
females with asthma is associated to improvement of
respiratory symptoms, rescue medication use and lung
function.
To assess the symptoms and the use of rescue medication
in our study we have used the ACT.18 ACT is a clinically valid
measure that can be useful to clinicians and might be useful
in assessing asthma control in the same patient populations,
which requires only that the patients properly report their
symptoms and rescue medication use.19
There have been numerous reports in the literature
suggesting an association in adults and children between
wheezing, asthma and obesity, and a number of explanatory
hypotheses have been generated.6,26–28 Moreover, it has
been documented that weight gain more than 25 kg
increases fourfold the relative risk of asthma.29 In contrast
only few studies have examined the effect of a consistent
weight loss in severely obese asthmatics. Spivak et al.30
evaluated the improvement of obesity related illness
including asthma following bariatric surgery. In that study
analyzing the post-surgical follow-up of a large cohort of
patients, the effect of weight loss on obesity related illnessstatus was assessed by examining the reduction of drugs
prescription for each comorbidities before surgery and
during follow-up. Dixon et al.13 in an uncontrolled study
reported improvement in clinical scores of 32 asthmatics
obese after bariatric surgery. There was a highly significant
reduction at follow-up with significant improvements in all
aspects of asthma assessed, including severity, daily impact,
medications needed, hospitalization, sleep and exercise.
In the present study, both ACTand exhaled NO as a marker
of airway inflammation were obtained and compared to a
control group of asthmatic obese not receiving the surgical
procedure with similar lung function abnormalities and in
the absence of significant other cardio-respiratory comor-
bidities. We found a resolution of respiratory symptoms in
10 among 12 patients. Interestingly only patients in the OB
group were able to reach a full improvement of respiratory
symptoms in comparison to none of the obese asthmatics
who did not experience any weight loss.
This result obtained after weight reduction may depend
on several factors. First, in asthmatic patients, airway
obstruction causes early airway closure during expiration.
This feature is accentuated by obesity, especially when
patients are lying down.31 Noticeably, we did not find any
correlation between BMI and lung volumes in our female
subjects at a variance with recent study of Santana et al.32
who evaluated non-asthmatic subjects with severe morbid
obesity with even higher BMI and a significant smoker
prevalence; however, weight reduction reduces closing
capacity, which tends to increase the forced expiratory
volume in 1 s (FEV1) and the forced vital capacity (FVC); this
may also lead to a reduction in clinical symptoms in
asthmatic people.
Second, it has been proposed that the narrowed periph-
eral airways in obesity may cause increased airway respon-
siveness, as may the rapid shallow breathing pattern
observed in the morbidly obese, thus weight reduction
may reduce airway responsiveness. As obesity is associated
with both reduced chest wall compliance and increased
elastic load on respiratory muscle, improvement in lung
function with weight loss might be dependent on reduction
of these elastic loads independently from changes in airway
obstruction.33
Other proposed links between obesity and asthma include
gastro-oesophageal reflux,34 which is increased in obesity.
Gastro-oesophageal reflux may worsen asthma symptoms,
and reduction of fat around the abdomen may reduce reflux,
thus alleviating symptoms. However, none of our patients
referred gastroesophageal symptoms and preoperative
endoscopy resulted negative for lower esophageal sphincter
abnormalities. Also the psychological benefit of having lost
weight may also reduce symptoms.35
Finally, a low intake of antioxidants, and the production
of pro-inflammatory mediators from adipose tissue, causing
airway inflammation has been proposed as factors linking
obesity and asthma.36 The weight reduction induced by
bariatric surgery may have influenced these factors. How-
ever, in our obese patients after surgery, exhaled NO, which
is a common marker of airways inflammation in asthma,
remained unchanged. This may reflect the fact that,
whereas the overall clinical picture of the asthma was
improved by the weight reduction, airway inflammation
persisted.
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on exhaled NO should be considered. In fact in a previous
study we have shown that severe uncomplicated obese
subjects demonstrate low exhaled NO levels which normal-
ize after consistent weight loss.37 Therefore, a reduced
exhaled NO in our obese subjects after surgery might be
counterbalanced by the increase in NO due to the weight
reduction. Accordingly, Komakula et al.38 have showed that
in asthmatics, exhaled NO declines with increasing BMI, and
showing that increased airway oxidative stress may explain
the reductions in NO. Consequently, NO may not be a good
marker of airway inflammation in the obese as it may be
produced at normal or elevated levels but then degraded by
oxidative stress.
The improvement in the ACT score observed in the OB
group might be linked to the improvement in the overall
respiratory symptoms and not to the specific disease, as we
found an improvement in the global lung function after
surgery. In fact both FEV1 and FVC increased in symmetric
fashion, suggesting an improvement in restrictive lung
disease. However, both baseline and after surgery lung
function did not demonstrate marked impairment; more-
over, it is unlikely that the ACT may have simply been
changed due to reduction in obesity related dyspnea as
rescue brochodilatators were effective into symptom
relieving. Actually, a modified ACT with the three first
questions administrated to a large group of non-asthmatic
obese scheduled for bariatric surgery did not show any
significant score decrease (data not shown). Finally, as
recently reported in post-hoc analysis of pharmacology
trials, while BMI may influence the response to controller
drugs in asthma, there was no correlation between BMI and
use of beta stimulants.39
Our study has some limitations. It was unblinded and not
randomised as the control group was represented by
subjects who decided to delay the scheduled operation
for reasons unrelated to their asthma or other health
problems. Furthermore, we did not evaluate if the improve-
ment in the control of the asthma was related to the
reduction in the airway hyper-reactivity. However, in a
previous study persistence in airways hyper-reactivity
after weight reduction has been reported.27 Finally, the
patients presented mostly intermittent or mild persistent
asthma with lung function nearly normal and this of course
reduced the room for improvement. This bias was due to the
protocol of our surgical department, which excludes from
the list of bariatric surgery patients with more severe
asthma.
In conclusion, the weight reduction induced by
bariatric surgery in severely obese females with asthma
is associated to improvement of respiratory symptoms,
use of rescue medication and lung function. The mecha-
nisms underlying the effects of consistent weight loss on
asthma in severe obese subjects would require further
studies.Conflict of interest
None of the authors have a conflict of interest to declare in
relation to this work.References
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